论文信息 - Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy. - 字舞流文

Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.

D. Cunningham | E. Bayever | Chung-Pin Li | Li‐Tzong Chen | F. Braiteh | J. Blanc | R. Hubner | J. Siveke | G. Schwartsmann | T. Macarulla | C. Chiu | Y. Shan | Kyung-Hun Lee | D. D. Hoff | V. Moyo | A. Wang-Gillam | A. Dean | G. Jameson | B. Belanger | György Bodoky